Pathstone Holdings, LLC Macrogenics Inc Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 15,894 shares of MGNX stock, worth $59,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,894
Previous 17,687
10.14%
Holding current value
$59,920
Previous $75,000
30.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MGNX
# of Institutions
143Shares Held
59.1MCall Options Held
143KPut Options Held
259K-
Bellevue Group Ag Kuesnacht, V89.94MShares$37.5 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY6MShares$22.6 Million0.33% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$16.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.31MShares$12.5 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $232M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...